Skip to content

EBITDA at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$35.6M+132%
LBR
LB Pharmaceuticals Inc Common StockLBRX
-$18.97M-263%
Stereotaxis logo
StereotaxisSTXS
-$5.59M-0.5%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$5.51M-8.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.39M-38.5%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-56.2%
Enterprise value$162.64M-42.0%
P/S0.6×-1.3×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Calculated from Neuronetics’s reported figures.

$9.0Mebit+
$745.0KDepreciation Depletion & Amortization
=-$8.25M

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's EBITDA?
Neuronetics (STIM) reported EBITDA of -$8.25M in Q1 2026.
How has Neuronetics's EBITDA changed year-over-year?
Neuronetics's EBITDA increased by 18.3% year-over-year, from -$10.1M to -$8.25M.
What is the long-term trend for Neuronetics's EBITDA?
Over 4 years (2021 to 2025), Neuronetics's EBITDA has grown at a 1.4% compound annual growth rate (CAGR), from -$26.5M to -$27.97M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.